Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024

• Recce recognized by the United Kingdom Government Innovation Agency among the most promising organizations for the UK AMR Inward Mission 2024
  
• Recce chosen as one of 18 organizations globally for its potential to tackle the global health threat of AMR and superbugs
• Professor Dame Sally Davies, former England Chief Medical Officer, hosting a reception with selected organizations offering Recce strategic partnering opportunities in the AMR space
  

SYDNEY, Australia, April 09, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced its selection by the United Kingdom’s (UK) Government Innovation Agency (Innovate UK) to partake in the prestigious UK Antimicrobial Resistance (AMR) Inward Mission 2024. This event, set to take place from June 2-7, 2024, will spotlight the Company as one of the promising organizations from across the globe recognized for its potential to combat AMR.

“We are thrilled by the opportunity to collaborate with the UK’s leading AMR experts and institutions and thank the UK government for their support,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals. “We believe this mission will be a catalyst for our continued growth and success in developing potentially life-saving antimicrobial treatments.”

Innovate UK’s rigorous selection process identified Recce as one of 18 organizations in the world from a large competitive pool of international candidates (Australia, Canada, France, India, Italy, Netherlands, Nigeria, Norway, Switzerland, and the USA), highlighting its innovative approach and potential to synergize with the UK’s AMR industry leaders.

The UK AMR Inward Mission 2024 will host a comprehensive program, including partnering sessions, visits to world-class AMR infrastructure, and interactions with key opinion leaders. A highlight of the event will be a reception in Cambridge with Professor Dame Sally Davies, former England Chief Medical Officer who acted as the UK government’s principal medical adviser and the professional head of all directors of public health in local government.

The selection of Recce for the UK AMR Inward Mission signifies an important geographic opportunity in its global strategy, particularly in establishing a foothold in the UK’s vibrant AMR research and development ecosystem. This engagement will enable Recce to forge essential partnerships, gain insights into regulatory pathways, and explore new markets, ultimately advancing its mission to provide innovative solutions to the pressing global health challenge of AMR.